BET-BAY 002 (S enantiomer)
Code | Size | Price |
---|
TAR-T10517-25mg | 25mg | £1,461.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T10517-50mg | 50mg | £2,154.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
BET-BAY 002 S enantiomer is an enantiomer of BET-BAY 002 which is a BET inhibitor.
CAS:
T10517
Formula:
C22H18ClN5O
Molecular Weight:
403.86
Purity:
0.98
SMILES:
CC1=NN=C2N1C3=CC=CC=C3C(C4=CC=C(Cl)C=C4)=C[C@@H]2CC5=NN=C(C)O5
References
1. Evans DM,?et al. Exposure?time?versus?cytotoxicity?for?anticancer agents.Cancer Chemother Pharmacol.?2019 Aug;84(2):359-371.
2. Jung M,?et al. Targeting?BET?bromodomains?for?cancer?treatment. Epigenomics.?2015;7(3):487-501.